BAMS
TNDM icon

Bellevue Asset Management (Switzerland)’s Tandem Diabetes Care TNDM Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,000
Closed -$542K – 138
2015
Q2 		$542K Hold
5,000
– – 0.08% 125
2015
Q1 		$631K Buy
+5,000
New +$650K 0.09% 128

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s TNDM Position: Q3 2015 in Review

Bellevue Asset Management (Switzerland) sold out of Tandem Diabetes Care (TNDM) in Q3 2015, closing a stake of 5,000 shares — an estimated $542K sold.

Bellevue Asset Management (Switzerland) first reported a position in TNDM in Q1 2015 and held it in 2 quarters. The position peaked at $631K in Q1 2015. 85 funds tracked by Wall St. Rank hold TNDM as of Q3 2015.

  • Bellevue Asset Management (Switzerland) reported no remaining Tandem Diabetes Care position as of Q3 2015 after selling out during the quarter.
  • Bellevue Asset Management (Switzerland) sold 5,000 Tandem Diabetes Care shares in Q3 2015, an estimated $542K.
  • Bellevue Asset Management (Switzerland) first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 2 quarters.
  • Bellevue Asset Management (Switzerland)'s Tandem Diabetes Care position peaked at $631K in Q1 2015.
  • 85 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q3 2015, filed 12 Nov 2015.